XML 16 R6.htm IDEA: XBRL DOCUMENT v3.8.0.1
Condensed Consolidated Statements of Cash Flow - USD ($)
$ in Thousands
3 Months Ended
Oct. 28, 2017
Oct. 29, 2016
Cash Flows from Operating Activities    
Net income $ 13,488 $ 13,243
Adjustments to reconcile net income to net cash provided by operating activities:    
Deferred income taxes (1,366) (648)
Remeasurement of preferred stock warrant liability (9,071) 1,503
Inventory reserve 4,224 1,933
Stock-based compensation expense 2,038 610
Depreciation and amortization 2,270 1,461
Loss on disposal of property and equipment 131 27
Change in operating assets and liabilities:    
Inventory (24,208) (10,142)
Prepaid expenses and other assets 4,084 (34)
Accounts payable 13,967 7,682
Accrued liabilities 16,942 21,119
Deferred revenue 1,663 2,173
Gift card liability (119) (48)
Other liabilities 748 2,725
Net cash provided by operating activities 24,791 41,604
Cash Flows from Investing Activities    
Purchase of property and equipment (4,180) (5,478)
Proceeds from sale of property and equipment   31
Net cash used in investing activities (4,180) (5,447)
Cash Flows from Financing Activities    
Proceeds from the exercise of stock options 444 206
Repurchase of common stock related to early exercised options (39)  
Payment of deferred offering costs (528)  
Net cash (used in) provided by financing activities (123) 206
Net increase in cash and restricted cash 20,488 36,363
Cash and restricted cash at beginning of period 119,958 101,492
Cash and restricted cash at end of period 140,446 137,855
Components of cash and restricted cash    
Cash 131,096 127,114
Restricted cash 250 1,391
Restricted cash, net of current portion 9,100 9,350
Cash and restricted cash at end of period 140,446 137,855
Supplemental Disclosure    
Cash paid for income taxes   8,749
Supplemental Disclosure of Non-Cash Investing and Financing Activities:    
Purchases of property and equipment included in accounts payable and accrued liabilities 1,022 4,303
Capitalized stock-based compensation 121 22
Vesting of early exercised options 315 $ 229
Deferred offering costs included in accounts payable and accrued liabilities $ 920